Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sevelamer in Proteinuric CKD (ANSWER)
NCT01968759Phase 2Completed
- Sponsor
- Mario Negri Institute for Pharmacological Research
- Start
- Oct 2013
- Primary completion
- Oct 2015
- Modality
- Polymer-based Nanoparticles, Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of sevelamer carbonate in chronic kidney disease (CKD), sponsored by Mario Negri Institute for Pharmacological Research. Started Oct 2013; status: completed.
02
Drugs
sevelamer carbonate
03
Conditions
chronic kidney disease (CKD)
Beyond the preview
Go deeper on NCT01968759.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01968759.